Tradestie Institutional Equity Comparison Engine
NMR vs CGABL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NMR Overall Edge
NMR Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nomura Holdings, Inc (NMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMR trades at 11.4x Forward P/E with 25.1% operating margin (+17.9% YoY revenue) versus CGABL at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NMR sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against CGABL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
NMR
NMR 11.4x vs CGABL N/M Fwd P/E
Growth & Margin Winner
NMR
Op Margin 25.1% vs 0.0% ยท YoY +17.9% vs +0.0%
Momentum & Technical Winner
NMR
1Y +21.8% vs -16.6% ยท 52W Pos 40% vs 16%
Options & Structure Winner
NMR
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
NMR
NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$8.51
-5.86% 1D
Market Cap
$26.4B
1M Return
-5.86%
1Y Return
+21.75%
Forward P/E
11.4x
Unified AI Score
35.0 / 100
SELL
Tech 13.0
Fund 35.0
Flow 50.0
Mom 50.0
CGABL
NASDAQ
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
Institutional Equity
$14.68
+1.87% 1D
Market Cap
$16.1B
1M Return
-2.65%
1Y Return
-16.64%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 75.0
Fund 62.0
Flow 50.0
Mom 58.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMR +21.75%
CGABL -16.64%
Spread: +38.39 pp (NMR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NMR TTM Op. Margin: 25.1%
CGABL TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMR vs CGABL. Trailing 12-month operating profitability (NMR 25.1% vs CGABL 0.0%) and valuation multiples (NMR 11.4x vs CGABL N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMR | CGABL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $26.4B | $16.1B | Larger Scale | NMR |
| Trailing P/E Ratio Valuation | 10.4x | N/M | Lower Multiple | NMR |
| Forward P/E Ratio Valuation | 11.4x | N/M | Lower Multiple | NMR |
| Revenue Growth (YoY) Growth | +17.9% | +0.0% | Higher Growth | NMR |
| Operating Margin (TTM) Profitability | 25.1% | 0.0% | Higher Margin | NMR |
| Net Profit Margin Profitability | 17.1% | 0.0% | Higher Margin | NMR |
| Return on Equity (ROE) Capital Efficiency | 11.5% | 68.7% | Higher ROE | CGABL |
| 52-Week Range Position Momentum | 40% ($7โ$11) | 16% ($14โ$18) | Stronger Trend | NMR |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 34% Vol | 0.36ฮฒ ยท 28% Vol | Lower Realized Risk | CGABL |
| Unified Institutional Score Composite Signal | 35.0 / 100 (SELL) | 52.1 / 100 (HOLD) | Higher Composite | CGABL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMR vs CGABL Buy Guide
NMR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
CGABL
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMR nor CGABL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.